Home 2023

Liver cancer

StockWatch: Novo Nordisk Shares Soar as Ozempic Aces Phase III CKD Trial
Drug Discovery

StockWatch: Novo Nordisk Shares Soar as Ozempic Aces Phase III CKD Trial

Alex Philippidis -
0
Tumor Development Driven by Metabolites
Cancer

Tumor Development Driven by Metabolites

Christina Jackson -
0
Trio of Immune Cells Critical for Liver Cancer Immunotherapy
Cancer

Trio of Immune Cells Critical for Liver Cancer Immunotherapy

Christina Jackson -
0
Cancer Risk Link to Fat Accumulation and Distribution May Depend on Sex
Cancer

Cancer Risk Link to Fat Accumulation and Distribution May Depend on Sex

Sophia Ktori -
0
Liver Cancer Progression Promoted by B Cells’ Dual Strategy
Cancer

Liver Cancer Progression Promoted by B Cells’ Dual Strategy

Christina Jackson -
0
Organoids and CRISPR-Cas9 Provide Insights into Rare Liver Cancer
Cancer

Organoids and CRISPR-Cas9 Provide Insights into Rare Liver Cancer

Christina Jackson -
0
Liver Cancer Finding May Lead to New Class of Antitumor Therapies
News

Liver Cancer Finding May Lead to New Class of Antitumor Therapies

John Sterling -
0
Top 10 Ambition: Bayer Aims for $10 Billion in Cancer Drug Sales by 2030
Cancer

Top 10 Ambition: Bayer Aims for $10 Billion in Cancer Drug Sales by 2030

Alex Philippidis -
0
First Application of AlphaFold in Identifying Potential Liver Cancer Drug
Artificial Intelligence

First Application of AlphaFold in Identifying Potential Liver Cancer Drug

Anjali A. Sarkar, PhD -
0
Charles River and Rznomics Partner on RNA-based Anticancer Gene Therapy Manufacturing
Bioprocessing

Charles River and Rznomics Partner on RNA-based Anticancer Gene Therapy Manufacturing

John Sterling -
0
123...15Page 1 of 15
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.